LIGAND PHARMACEUTICALS INCORPORATED Current Assets
LIGAND PHARMACEUTICALS INCORPORATED (LGND) had Current Assets of $1.46 billion as of 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-07
- 2026-06-30: Assets, Current $1.46B.
- 2026-03-31: Assets, Current $865.41M.
- 2025-12-31: Assets, Current $832.27M.
- 2025-09-30: Assets, Current $753.92M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $1.46B 10-Q · filed 2026-08-07 | |
| 2026-03-31 | $865.41M 10-Q · filed 2026-05-08 | |
| 2025-12-31 | $832.27M 10-Q · filed 2026-08-07 | |
| 2025-09-30 | $753.92M 10-Q · filed 2025-11-07 | |
| 2025-06-30 | $352.94M 10-Q · filed 2025-08-08 | |
| 2025-03-31 | $309.32M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $331.56M 10-K · filed 2026-02-27 | |
| 2024-09-30 | $309.39M 10-Q · filed 2024-11-08 | |
| 2024-06-30 | $312.26M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $368.91M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $237.43M 10-K · filed 2025-02-28 | |
| 2023-09-30 | $253.99M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $276.71M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $328.19M 10-Q · filed 2023-05-08 | |
| 2022-12-31 | $263.60M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $220.43M 10-Q · filed 2022-11-08 | |
| 2022-06-30 | $243.78M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $276.07M 10-Q · filed 2022-05-09 | |
| 2021-12-31 | $464.75M 10-K · filed 2023-02-28 | |
| 2021-09-30 | $432.08M 10-Q · filed 2021-11-09 | |
| 2021-06-30 | $410.90M 10-Q · filed 2021-08-03 | |
| 2021-03-31 | $437.43M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $500.56M 10-K · filed 2022-02-28 | |
| 2020-09-30 | $857.74M 10-Q · filed 2020-11-06 | |
| 2020-06-30 | $863.62M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $830.73M 10-Q · filed 2020-05-08 | |
| 2019-12-31 | $1.12B 10-K · filed 2021-02-24 | |
| 2019-09-30 | $1.18B 10-Q · filed 2019-11-08 | |
| 2019-06-30 | $1.44B 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $1.57B 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $870.54M 10-K · filed 2020-02-27 | |
| 2018-09-30 | $1.75B 10-Q · filed 2018-11-08 | |
| 2018-06-30 | $1.48B 10-Q · filed 2018-08-08 | |
| 2018-03-31 | $349.05M 10-Q · filed 2018-05-09 | |
| 2017-12-31 | $237.02M 10-K · filed 2019-02-28 | |
| 2017-09-30 | $224.20M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $197.18M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $174.70M 10-Q · filed 2017-05-09 | |
| 2016-12-31 | $163.05M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $140.69M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $126.56M 10-Q · filed 2016-11-14 | |
| 2016-03-31 | $133.06M 10-Q · filed 2016-11-14 | |
| 2015-12-31 | $214.71M 10-K · filed 2017-02-28 | $215.57M 10-K · filed 2016-02-26 |
| 2015-09-30 | $210.32M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $196.72M 10-Q · filed 2015-08-05 | |
| 2015-03-31 | $191.71M 10-Q · filed 2015-05-11 | |
| 2014-12-31 | $185.16M 10-K · filed 2016-11-14 | $24.88M 10-K · filed 2014-12-01 |
| 2014-09-30 | $198.52M 10-Q · filed 2014-10-31 | |
| 2014-06-30 | $28.59M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $33.40M 10-Q · filed 2014-05-07 | |
| 2013-12-31 | $24.88M 10-K · filed 2015-02-23 | |
| 2013-09-30 | $16.64M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $14.57M 10-Q · filed 2013-08-01 | |
| 2013-03-31 | $17.74M 10-Q · filed 2013-05-08 | |
| 2012-12-31 | $23.82M 10-K/A · filed 2014-12-12 | |
| 2012-09-30 | $17.43M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $21.10M 10-Q/A · filed 2012-11-14 | |
| 2012-03-31 | $23.54M 10-Q/A · filed 2012-11-14 | |
| 2011-12-31 | $32.23M 10-K · filed 2013-03-14 | |
| 2011-09-30 | $26.82M 10-Q/A · filed 2012-02-10 | |
| 2011-06-30 | $28.14M 10-Q/A · filed 2012-02-10 | |
| 2010-12-31 | $37.02M 10-K/A · filed 2012-11-14 |